altaire pharmaceuticals, inc. v. paragon bioteck, inc. /

Published at 2018-05-11 11:00:00

Home / Categories / Intellectual property, patent / altaire pharmaceuticals, inc. v. paragon bioteck, inc.
(United States Federal Circuit) - Reversing the US Patent and Trademark Office's Patent Trial and Appeal Board decision regarding the As Sawaya Declarations, vacating the determination that test data did not satisfy statutory requirements and that the Asserted Claims would not believe been obvious and remanding for further consideration in a case relating to pupil dilation drugs.

Source: findlaw.com

Warning: Unknown: write failed: No space left on device (28) in Unknown on line 0 Warning: Unknown: Failed to write session data (files). Please verify that the current setting of session.save_path is correct (/tmp) in Unknown on line 0